Patient Burden in Dystonia Diagnosis and Botulinum Toxin Treatment: A Nationwide Survey in Turkey
Brain and Behavior · 2025-03 · 15 (3)
DOI: 10.1002/brb3.70325 ↗Kurz gefasst
Multizentrische Studie in der Zeitschrift Brain and Behavior, online erschienen am 28.02.2025. Verfasst von Rezzak Yilmaz und 10 weiteren Autor:innen. Beteiligte Einrichtung: Department of Neurology, Ankara University School of Medicine, Ankara, Turkey. Hauptthemen laut MEDLINE: Botulinum Toxins, Cost of Illness, Dystonic Disorders, Dystonia. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 29 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Background
Understanding real‐world experiences is crucial in determining the potential gaps in patient‐centered healthcare in dystonia. We explored the challenges of people with dystonia (PwD) at the stages of diagnosis and botulinum neurotoxin (BoNT) treatment.
Methods
A multicenter survey was conducted face‐to‐face across seven university hospitals in Turkey. PwD receiving BoNT treatment for at least 6 months were invited. Data on demographics, diagnostic journeys, and treatment experiences were collected and analyzed using descriptive statistics and regression models.
Results
A total of 789 PwD participated, reporting significant burdens during both diagnostic and treatment stages. Diagnosis was delayed by approximately 1 year, with 15% receiving incorrect initial diagnoses. Additionally, 30.7% of PwD traveled to another city, and 42.6% applied to private clinics for diagnosis, leading to a substantial logistic and financial burden. The treatment stage revealed that a quarter of PwD had to travel significant distances every 3 months, or applied to a private clinic to receive BoNT injections, creating considerable cost and effort. In addition, PwD with oromandibular dystonia were three times and task‐specific dystonia were around nine times less likely to be satisfied with BoNT treatment compared to facial dystonia. Alternative treatment was reported in 11%, with no substantial benefit.
Conclusions
The findings highlight critical unmet needs in the diagnostic and treatment processes for PwD. These include improvement in diagnostic accuracy, reduced travel and financial burdens, and enhanced treatment satisfaction. An action plan emphasizing resource utilization policies and educational activities for healthcare providers is essential to address these challenges.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Neurology, Ankara University School of Medicine, Ankara, Turkey.
- Brain Research Center, Ankara University, Ankara, Turkey.
- Department of Neurology, Mersin University School of Medicine, Mersin, Turkey.
- Department of Neurology, Atatürk University School of Medicine, Erzurum, Turkey.
- Behavioral Neurology and Movement Disorders Unit, Department of Neurology, Istanbul Faculty of Medicine, Istanbul University, Istanbul, Turkey.
- Department of Neurology, Ege University School of Medicine, Izmir, Turkey.
ORCID-Profile: Rezzak Yilmaz, Bedia Samanci, Nazlı Durmaz Çelik
Zitieren
APA
Yilmaz, R., Öksüz, N., Ceylan, M., Samanci, B., Acarer, A., Durmaz Çelik, N., Erdem Tilki, H., Özkan, S., Hanağası, H., Dogu, O., & Akbostancı, M. C. (2025). Patient Burden in Dystonia Diagnosis and Botulinum Toxin Treatment: A Nationwide Survey in Turkey. Brain and Behavior, 15(3). https://doi.org/10.1002/brb3.70325
Vancouver
Yilmaz R, Öksüz N, Ceylan M, Samanci B, Acarer A, Durmaz Çelik N, et al. Patient Burden in Dystonia Diagnosis and Botulinum Toxin Treatment: A Nationwide Survey in Turkey. Brain and Behavior. 2025;15(3). doi:10.1002/brb3.70325
BibTeX
@article{Yilmaz2025,
author = {Yilmaz, Rezzak and Öksüz, Nevra and Ceylan, Mustafa and Samanci, Bedia and Acarer, Ahmet and Durmaz Çelik, Nazlı and Erdem Tilki, Hacer and Özkan, Serhat and Hanağası, Haşmet and Dogu, Okan and Akbostancı, M Cenk},
title = {Patient Burden in Dystonia Diagnosis and Botulinum Toxin Treatment: A Nationwide Survey in Turkey},
journal = {Brain and Behavior},
year = {2025},
volume = {15},
number = {3},
doi = {10.1002/brb3.70325}
}
EUVIMED